O-85 Comorbidities and mortality during the SARSCoV- 2 outbreak in Grenada
Author(s):
V Matthew-Belmar, A Alhassan, N Cudjoe , S Charles , L Mark , T Noel, C Oura, CNL Macpherson
Year of Presentation:
2026
Objective: To examine gender differences in age at death,
comorbidity burden, and specific comorbid conditions
among confirmed COVID 19 deaths in Grenada, and to
assess parish level variations in COVID 19 mortality rates.
Methods: A retrospective descriptive method was conducted with confirmed COVID-19 deaths from the Ministry of Health during the SARS-CoV-2 outbreak in Grenada from January 2021 to June 2022.
Results: A total of 288 confirmed COVID-19 deaths were included, of which 47.6% were female and 52.4% were male. The overall mean age at death was 74 years (SD=16.49 ), with females being older at death than males. Females also had a higher mean number of comorbidities compared with males. The most frequently documented comorbid conditions were hypertension, respiratory disease, and diabetes. Females had higher proportions of diabetes, hypertension, and respiratory disease than males. In age adjusted logistic regression models using males as the reference group, females had higher odds of hypertension (aOR=1.73; 95% CI: 1.07–2.79) and respiratory disease (aOR=1.71; 95% CI: 1.06–2.76), while the association with diabetes was borderline significant (aOR=1.64; 95% CI: 1.00–2.69). No significant gender differences were observed for heart disease, kidney disease, cancer, or other comorbidities. Parish level analyses showed heterogeneity in mortality rates, with higher rates in St. Patrick and St. John, and lower rates in St. George and Carriacou & Petite Martinique.
Conclusion: The mortality rate for COVID-19 individuals were 1.8 % from January 2021 to June 2022. More males died from COVID-19 than females. Pneumonia, hypertension & respiratory disease and diabetes, were the most common morbidity identified in patient deaths due to COVID-19 in Grenada. Most of the patients had two or more comorbities.